The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single center study of efficacy and safety of capivasertib in hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC).
 
Utsav Joshi
No Relationships to Disclose
 
Junmin Whiting
No Relationships to Disclose
 
Jorge Avila
Consulting or Advisory Role - Lilly
 
Melissa Armitage
No Relationships to Disclose
 
Pravash Budhathoki
No Relationships to Disclose
 
Pujan Patel
No Relationships to Disclose
 
Fatima Tuz Zahra
No Relationships to Disclose
 
Avan Armaghani
No Relationships to Disclose
 
Aixa Soyano Muller
Honoraria - FLASCO; MDoutlook; OncLive/MJH Life Sciences; OncLive/MJH Life Sciences
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis
Research Funding - Haystack Oncology (Inst)
 
Ricardo Costa
Stock and Other Ownership Interests - Dare Bioscience; Spero Therapeutics
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Sermonix Pharmaceuticals
 
Loretta Loftus
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson; Lilly; Pfizer
Honoraria - Targeted Oncology
Consulting or Advisory Role - Biovica
 
Tracey O'Connor
No Relationships to Disclose
 
Hatem Soliman
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Lilly; Novartis; Puma Biotechnology; Seagen; Sermonix Pharmaceuticals
Speakers' Bureau - Merck
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Hyo Han
Consulting or Advisory Role - Arvinas; Pfizer
Research Funding - Arvinas (Inst); Celcuity (Inst); Department of Defense (Inst); Eisai; Ellipses Pharma; Mersana; Pfizer (Inst); Phoenix Pharmaceuticals (Inst); Pionyr (Inst); QuantumLeap Health (Inst); Senhwa Biosciences (Inst); Zymeworks (Inst)